vs

Side-by-side financial comparison of agilon health, inc. (AGL) and Lineage, Inc. (LINE). Click either name above to swap in a different company.

agilon health, inc. is the larger business by last-quarter revenue ($1.6B vs $1.4B, roughly 1.1× Lineage, Inc.). Lineage, Inc. runs the higher net margin — -7.3% vs -12.0%, a 4.8% gap on every dollar of revenue. On growth, Lineage, Inc. posted the faster year-over-year revenue change (3.1% vs 3.1%). Lineage, Inc. produced more free cash flow last quarter ($35.0M vs $-23.5M).

agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.

Norwegian Cruise Line Holdings (NCLH) is a holding company that is based in the United States and domiciled in Bermuda. It operates three cruise lines as wholly owned subsidiaries: Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. With its subsidiaries combined, it is the third-largest cruise operator in the world. It is a publicly traded company listed on the New York Stock Exchange.

AGL vs LINE — Head-to-Head

Bigger by revenue
AGL
AGL
1.1× larger
AGL
$1.6B
$1.4B
LINE
Growing faster (revenue YoY)
LINE
LINE
+0.1% gap
LINE
3.1%
3.1%
AGL
Higher net margin
LINE
LINE
4.8% more per $
LINE
-7.3%
-12.0%
AGL
More free cash flow
LINE
LINE
$58.5M more FCF
LINE
$35.0M
$-23.5M
AGL

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AGL
AGL
LINE
LINE
Revenue
$1.6B
$1.4B
Net Profit
$-188.9M
$-100.0M
Gross Margin
32.3%
Operating Margin
-12.3%
2.5%
Net Margin
-12.0%
-7.3%
Revenue YoY
3.1%
3.1%
Net Profit YoY
-78.5%
79.4%
EPS (diluted)
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGL
AGL
LINE
LINE
Q4 25
$1.6B
Q3 25
$1.4B
$1.4B
Q2 25
$1.4B
$1.4B
Q1 25
$1.5B
$1.3B
Q4 24
$1.5B
$1.3B
Q3 24
$1.5B
$1.3B
Q2 24
$1.5B
$1.3B
Q1 24
$1.6B
$1.3B
Net Profit
AGL
AGL
LINE
LINE
Q4 25
$-188.9M
Q3 25
$-110.2M
$-100.0M
Q2 25
$-104.4M
$-6.0M
Q1 25
$12.1M
$0
Q4 24
$-105.8M
$-71.0M
Q3 24
$-117.6M
$-485.0M
Q2 24
$-30.7M
$-68.0M
Q1 24
$-6.1M
$-40.0M
Gross Margin
AGL
AGL
LINE
LINE
Q4 25
Q3 25
32.3%
Q2 25
31.9%
Q1 25
32.2%
Q4 24
32.3%
Q3 24
32.8%
Q2 24
33.4%
Q1 24
33.4%
Operating Margin
AGL
AGL
LINE
LINE
Q4 25
-12.3%
Q3 25
-9.1%
2.5%
Q2 25
-8.3%
1.7%
Q1 25
-1.4%
4.3%
Q4 24
-7.1%
-1.6%
Q3 24
-9.2%
-38.6%
Q2 24
-2.9%
5.5%
Q1 24
-0.4%
7.6%
Net Margin
AGL
AGL
LINE
LINE
Q4 25
-12.0%
Q3 25
-7.7%
-7.3%
Q2 25
-7.5%
-0.4%
Q1 25
0.8%
Q4 24
-6.9%
-5.3%
Q3 24
-8.1%
-36.3%
Q2 24
-2.1%
-5.1%
Q1 24
-0.4%
-3.0%
EPS (diluted)
AGL
AGL
LINE
LINE
Q4 25
Q3 25
$-0.44
Q2 25
$-0.03
Q1 25
$0.01
Q4 24
$-0.52
Q3 24
$-2.44
Q2 24
$-0.46
Q1 24
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGL
AGL
LINE
LINE
Cash + ST InvestmentsLiquidity on hand
$173.7M
Total DebtLower is stronger
$35.0M
Stockholders' EquityBook value
$126.7M
$8.4B
Total Assets
$1.3B
$19.2B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGL
AGL
LINE
LINE
Q4 25
$173.7M
Q3 25
$171.7M
Q2 25
$171.4M
Q1 25
$136.9M
Q4 24
$188.2M
$173.0M
Q3 24
$148.2M
$409.0M
Q2 24
$109.5M
$73.0M
Q1 24
$111.7M
Total Debt
AGL
AGL
LINE
LINE
Q4 25
$35.0M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AGL
AGL
LINE
LINE
Q4 25
$126.7M
Q3 25
$306.1M
$8.4B
Q2 25
$408.9M
$8.6B
Q1 25
$500.3M
$8.6B
Q4 24
$471.0M
$8.6B
Q3 24
$574.9M
$9.0B
Q2 24
$676.6M
$4.9B
Q1 24
$689.3M
$5.6B
Total Assets
AGL
AGL
LINE
LINE
Q4 25
$1.3B
Q3 25
$1.6B
$19.2B
Q2 25
$1.7B
$19.4B
Q1 25
$1.9B
$18.8B
Q4 24
$1.7B
$18.7B
Q3 24
$2.1B
$19.3B
Q2 24
$2.2B
$18.8B
Q1 24
$2.3B
Debt / Equity
AGL
AGL
LINE
LINE
Q4 25
0.28×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGL
AGL
LINE
LINE
Operating Cash FlowLast quarter
$-20.5M
$230.0M
Free Cash FlowOCF − Capex
$-23.5M
$35.0M
FCF MarginFCF / Revenue
-1.5%
2.5%
Capex IntensityCapex / Revenue
0.2%
14.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-119.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGL
AGL
LINE
LINE
Q4 25
$-20.5M
Q3 25
$-18.2M
$230.0M
Q2 25
$-35.1M
$258.0M
Q1 25
$-32.0M
$139.0M
Q4 24
$16.4M
Q3 24
$-7.7M
$186.0M
Q2 24
$-18.7M
$155.0M
Q1 24
$-47.8M
$105.0M
Free Cash Flow
AGL
AGL
LINE
LINE
Q4 25
$-23.5M
Q3 25
$-21.3M
$35.0M
Q2 25
$-38.3M
$95.0M
Q1 25
$-35.8M
$-12.0M
Q4 24
$13.2M
Q3 24
$-11.2M
$33.0M
Q2 24
$-22.0M
$-31.0M
Q1 24
$-50.9M
$-42.0M
FCF Margin
AGL
AGL
LINE
LINE
Q4 25
-1.5%
Q3 25
-1.5%
2.5%
Q2 25
-2.7%
7.0%
Q1 25
-2.3%
-0.9%
Q4 24
0.9%
Q3 24
-0.8%
2.5%
Q2 24
-1.5%
-2.3%
Q1 24
-3.2%
-3.2%
Capex Intensity
AGL
AGL
LINE
LINE
Q4 25
0.2%
Q3 25
0.2%
14.2%
Q2 25
0.2%
12.1%
Q1 25
0.3%
11.7%
Q4 24
0.2%
Q3 24
0.2%
11.5%
Q2 24
0.2%
13.9%
Q1 24
0.2%
11.1%
Cash Conversion
AGL
AGL
LINE
LINE
Q4 25
Q3 25
Q2 25
Q1 25
-2.64×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGL
AGL

Medical Services$1.6B100%
Other Operating$2.5M0%

LINE
LINE

Warehousing Operations$883.0M64%
Other$308.0M22%
Warehouse Lease$60.0M4%
Food Sales$52.0M4%
E Commerce And Other$46.0M3%
Railcar Lease$23.0M2%
Service Other$5.0M0%

Related Comparisons